Clinical trial • Phase I • Oncology
Clinical trial in Advanced solid tumors
Phase I trial for Advanced solid tumors. 69 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 10-09-2025
- First CTIS Authorization Date
- 15-01-2026
Trial design
Phase I trial across 11 sites in Spain, Ireland, Portugal.
- Target Sample Size
- 69
Recruitment
- Planned Sample Size
- 69
- Recruitment Window Months
- 25
Geography
- Total Number Of Sites
- 11
- Total Number Of Participants
- 31
Spain
- Earliest CTIS Part Ii Submission Date
- 02-12-2025
- Latest Decision Or Authorization Date
- 15-01-2026
- Processing Time Days
- 44
- Number Of Sites
- 8
- Number Of Participants
- 22
Sites
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- Oncology
- Contact Person Name
- Tatiana Hernández Guerrero
- Contact Person Email
- monica.alemany@start-barcelona.com
- Site Name
- Hospital San Pedro
- Department Name
- Oncology
- Contact Person Name
- María Jose de Miguel Luken
- Contact Person Email
- manuel.vaz@startrioja.com
- Site Name
- Clinica Universidad De Navarra
- Department Name
- Oncology
- Contact Person Name
- Bruno Sangro Gómez-Acebo
- Contact Person Email
- eecc@unav.es
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Contact Person Name
- Jaume Capdevila Castillon
- Contact Person Email
- pchiquillo@vhio.net
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Contact Person Name
- Manuel Pedregal Trujillo
- Contact Person Email
- docstartmadrid@startmadrid.com
- Site Name
- Hospital Universitario Virgen De La Victoria
- Department Name
- Oncology
- Contact Person Name
- Javier García Corbacho
- Contact Person Email
- mj.alba@ibima.eu
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Contact Person Name
- Emiliano Calvo Aller
- Contact Person Email
- dalmazio.danini@startmadrid.com
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- Oncology
- Contact Person Name
- Valentina Boni
- Contact Person Email
- ensayosnext.mad@quironsalud.es
Ireland
- Earliest CTIS Part Ii Submission Date
- 25-11-2025
- Latest Decision Or Authorization Date
- 16-01-2026
- Processing Time Days
- 52
- Number Of Sites
- 1
- Number Of Participants
- 3
Sites
- Site Name
- Mater Misericordiae University Hospital
- Department Name
- Oncology
- Contact Person Name
- Austin Duffy
- Contact Person Email
- austin.duffy@startdublin.com
Portugal
- Earliest CTIS Part Ii Submission Date
- 07-01-2026
- Latest Decision Or Authorization Date
- 16-01-2026
- Processing Time Days
- 9
- Number Of Sites
- 2
- Number Of Participants
- 6
Sites
- Site Name
- Start Research Portugal Unipessoal Lda.
- Contact Person Name
- André Mansinho
- Contact Person Email
- andre.mansinho@startlisbon.com
- Site Name
- Unidade Local De Saude De Gaia/Espinho E.P.E.
- Department Name
- Unidade de Fase 1
- Contact Person Name
- Andreia Capela
- Contact Person Email
- andreia.capela@ulsge.min-saude.pt
Sponsor
Primary sponsor
- Full Name
- Zymeworks Bc Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Canada
Related trials
Other published trials that may interest you.